Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Nnadozie Gabriel C.: Understanding Hemophilia – Modern Breakthroughs and the Gap in Global Access
Nnadozie Gabriel C./LinkedIn
Oct 3, 2026, 14:35

Nnadozie Gabriel C.: Understanding Hemophilia – Modern Breakthroughs and the Gap in Global Access

Nnadozie Gabriel C., Founder at TRiBE HQ, shared a post on LinkedIn:

“Hemophilia: When The Blood Struggles to Clot

What happens when a small cut refuses to stop bleeding?

For someone living with hemophilia, the problem is not that they have too much blood.

Their blood is missing or has very low levels of an important clotting factor needed to stop bleeding properly.

There are two common types:

  • Hemophilia A: Factor VIII is low or missing.
  • Hemophilia B: Factor IX is low or missing.

These factors help the body form a strong blood clot.

Without enough of them, bleeding can last longer than normal and may sometimes occur internally, especially in the joints and muscles.

Why does it mostly affect males?

Hemophilia A and B are usually X-linked inherited conditions. This means the faulty gene is carried on the X chromosome.

Because males have only one X chromosome, inheriting the faulty gene can result in hemophilia.

Females have two X chromosomes and are more commonly carriers, although females can also have hemophilia in certain circumstances.

Can hemophilia be treated?

Yes.

There is currently no simple permanent cure for most inherited cases, but effective treatments can greatly reduce bleeding and help people live active lives.

Treatment can include:

  • Clotting-factor replacement: replacing the missing Factor VIII or IX.
  • Other medicines: some treatments help the body produce or maintain clotting activity.
  • Gene therapy: for some eligible patients, gene therapy can provide a functional copy of the affected gene and potentially reduce the need for regular factor treatment. However, eligibility, availability, cost, and long-term outcomes remain important considerations.

What can we do?

Hemophilia is not simply a medical issue. It is also an issue of awareness, access, and affordability.

We need:

  • Earlier diagnosis
  • Better access to treatment
  • Affordable clotting-factor therapy
  • Genetic counselling for affected families
  • Greater public awareness
  • Stronger healthcare systems and specialist care

Most importantly, people living with hemophilia should not be defined by their condition.

With appropriate care, they can learn, work, study, build families, pursue their ambitions, and live productive lives.

Understanding the condition is the first step.

Access to proper care is the next.

As future healthcare professionals and members of society, we can help turn knowledge into better outcomes.

Repost if you value healthcare and awareness, someone might need this information right now.

Let’s learn, educate, advocate and save lives…”

Stay updated with Hemostasis Today.

Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Medicine Nnadozie Gabriel C.
NewsFeed